Business
Numeral To Exit Investments In Longevity And Isopharm
Numeral To Exit Investments In Longevity And Isopharm
About this update from Numeral Limited
Numeral Ltd JSE:XII:JSE: XII - UPDATE ON HEALTHCARE AND BIOTECH STRATEGY, INVESTMENTS AND THE FINALISATION OF AUDITED RESULTSNUMERAL - TO EXIT INVESTMENTS IN LONGEVITY AND ISOPHARMNUMERAL - INCREASES SHAREHOLDING IN CRYO-SAVE TO 51% FOR YEAR ENDED FEB 2026NUMERAL - MAKES FIRST STRATEGIC INVESTMENT IN WESTMED HEALTHCARE PLATFORMNUMERAL - LAUNCHES BOOST & RECOVERY PREMIUM WELLNESS AND RECOVERY CONCEPT